Reactive hyperemia
Cuff occlusion and release creates increased blood flow response.
A non-invasive module for evaluating vascular responsiveness and endothelial health through advanced measurements.

A body of medical literature exists which suggests that abnormal endothelial function is associated with atherosclerosis. Further, it has been established that endothelial function can be evaluated by observing hemodynamics in the hyperemic phase.
The Endogram works by occluding blood flow in the arm and then gauging the post-ischemic pulsatile component of flow and the artery's largest volume change. The dilation of the arterial segment is correlated with endothelial function, which is believed to be an early indicator of CAD.
The arterial wall is composed of four circular structures. The structure in contact with blood in the arteries is called the endothelium. Healthy endothelium releases nitric oxide when local blood flow increases, helping small arteries dilate and increasing blood flow at a reduced workload for the heart.
In diseased endothelium, increased local blood flow does not release adequate nitric oxide, and the response in arterial dilation and blood flow is blunted. The device measures the pulsatile component of flow before dilation, immediately after cuff release, and until flow returns to pre-occlusion levels.
The patented ENDogram technology received FDA approval for marketing while implemented in Model 300 as a standalone product and is positioned as part of the integrated Vascular Diagnostic Center.
The old screenshot-style material has been translated into clean cards, flows and data panels so users can read the product value clearly.
Cuff occlusion and release creates increased blood flow response.
Measures pulsatile component of flow before and after release.
Dilation pattern supports endothelial function evaluation.
Endothelial dysfunction may be an early CAD indicator.
PDFs, forms, brochures, FDA documentation and publications are available for customer review.